...
首页> 外文期刊>Urology >Improvement of hemostasis in open and laparoscopically performed partial nephrectomy using a gelatin matrix-thrombin tissue sealant (FloSeal).
【24h】

Improvement of hemostasis in open and laparoscopically performed partial nephrectomy using a gelatin matrix-thrombin tissue sealant (FloSeal).

机译:使用明胶基质-凝血酶组织封闭剂(FloSeal)改善开放式和腹腔镜部分肾切除术的止血效果。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVES: Long-term follow-up studies have demonstrated that effective local tumor control and long-term tumor-free progression rates can be achieved by nephron-sparing surgery. However, hemostasis is a major issue, and the lack of effective means of hemostasis has limited the wider use of the laparoscopic approach to nephron-sparing surgery. METHODS: Between January 2001 and April 2002, 25 patients with renal cell carcinoma were treated with partial nephrectomy using a two-component tissue sealant (FloSeal). The median age was 54 years (range 42 to 71). The follow-up time was 1 to 12 months (median 3.5). The tumor diameter ranged from 2 to 5 cm (median 2.8). Fifteen cases were performed by open retroperitoneal surgery, and 10 cases were performed laparoscopically. The two-component tissue sealant (consisting of a gelatin matrix granula component and a thrombin component) was applied after resection of the tumor and before perfusion of the kidney. The following parameters were recorded: time until complete hemostasis was achieved; decrease in postoperative hemoglobin level; postoperative bleeding; and presence or absence of a perirenal hematoma 24 hours and 10 days postoperatively by ultrasonography. RESULTS: After application of the tissue sealant for 1 to 2 minutes to the moist resection site, hemostasis was immediate in all cases. During the laparoscopically performed partial nephrectomies, a laparoscopic applicator was used to avoid wasting the tissue sealant within the dead space of the instrument. When reperfusion of the kidney was established, hemostasis was maintained. The decrease in postoperative hemoglobin level ranged from 0.3 to 1.2 points (median 0.7). None of the patients required blood transfusions. No postoperative bleeding occurred. The ultrasound examination 24 hours and 10 days postoperatively demonstrated the absence of a significant perirenal hematoma. CONCLUSIONS: The two-component tissue sealant FloSeal provided immediate and durable hemostasis in open and laparoscopically performed partial nephrectomies. The tissue sealant may provide a tool to expand the possibilities of laparoscopic nephron-sparing surgery.
机译:目的:长期随访研究表明,保留肾单位的手术可以实现有效的局部肿瘤控制和长期无肿瘤进展。然而,止血是一个主要问题,并且缺乏有效的止血手段限制了腹腔镜方法在保肾手术中的广泛使用。方法:2001年1月至2002年4月,采用两组分组织密封剂(FloSeal)对25例肾细胞癌患者进行了部分肾切除术。中位年龄为54岁(范围为42至71)。随访时间为1到12个月(中位数3.5)。肿瘤直径为2至5厘米(中位数2.8)。腹腔镜开腹手术15例,腹腔镜手术10例。在肿瘤切除之后和肾脏灌注之前,使用两组分组织密封剂(由明胶基质颗粒组分和凝血酶组分组成)。记录以下参数:达到完全止血的时间;术后血红蛋白水平降低;术后出血;超声检查术后24小时和10天是否存在肾周血肿。结果:在湿润切除部位应用组织密封剂1至2分钟后,所有病例均立即止血。在腹腔镜下进行部分肾切除术期间,使用腹腔镜涂药器避免浪费器械的死腔内的组织密封剂。建立肾脏再灌注后,止血得以维持。术后血红蛋白水平的下降幅度为0.3到1.2点(中位数为0.7)。没有病人需要输血。术后无出血发生。术后24小时和10天的超声检查表明没有明显的肾周血肿。结论:两组分组织密封剂FloSeal在开放和腹腔镜下进行的部分肾切除术中提供了立即和持久的止血作用。组织密封剂可以提供一种工具,以扩大腹腔镜保留肾单位的手术的可能性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号